Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor Read More »
Personalized Healthcare Evolves Around Partnerships
For 20 years, the promised future of personalized healthcare seemed elusive. Not anymore, thanks to innovative partners who are driving better outcomes.
Personalized Healthcare Evolves Around Partnerships Read More »
Flip the Script – Bryan S., PharmD
Trends and timely topics from the PharmD’s who give Rx Savings Solutions our unmatched clinical clout. Meet Bryan Schuessler, Director of Specialty Rx.
Delays or Not, Employers Should Still Prep for Transparency in Coverage
Despite enforcement delays, group health plans should keep moving toward price transparency. They have more to gain than compliance.
Delays or Not, Employers Should Still Prep for Transparency in Coverage Read More »
Infamous Combo-Drug Now Has a Generic Available
Generics are a no-brainer for cost savings, right? No such thing in pharmacy. Generic Duexis¨ just hit the market, with a price tag that’s still higher 20 times higher than a simple alternative.
You Pay How Much for These Drugs?
These products can slip by in a typical formulary review. They won’t show up in anyone’s Top 10 spends or have enough claims to be a target. But they can contribute big time to your annual spend.
Helping with the Heart of the Matter
February is American Heart Month, the perfect time to raise awareness of cardiovascular disease, as well as the small but meaningful part Rx Savings Solutions can play in fighting it.
Outlook 2020: Change Where You Look for Change
What can consumers and payers expect in 2020 when it comes to drug prices? Probably more of the same from the industry and Washington. Learn why our CEO is so optimistic that real change is already under way.
